Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2021-04-05 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于大博医疗科技股份有限公司2021年限制性股票激励计划（草案）的法律意见书
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding a 2021 restricted stock incentive plan (draft) for a listed company. It extensively discusses the legal compliance, eligibility, stock allocation, vesting conditions, and other regulatory requirements related to the stock incentive plan. The content is focused on the legal and regulatory aspects of a stock incentive plan rather than financial results, earnings, or management changes. It is not an announcement, transcript, or report of financial performance but a legal opinion on a specific corporate action related to equity incentives. This type of document fits best under the category of Regulatory Filings (RNS) as it is a compliance/legal opinion document related to a corporate governance matter and stock incentive plan, not a full annual report, earnings release, or management announcement.
2021-04-05 Chinese
2021年限制性股票激励计划实施考核管理办法
Governance Information Classification · 95% confidence The document is titled as the "2021 Restricted Stock Incentive Plan Implementation Assessment Management Measures" for a company. It details the purpose, principles, scope, assessment institutions, assessment indicators and standards, assessment period and frequency, procedures, and result management related to the company's restricted stock incentive plan. It is a governance-related document focusing on the company's internal rules and mechanisms for stock incentives, including performance targets and assessment criteria for executives and key personnel. There is no financial statement, earnings data, or regulatory filing announcement. It is not an annual or interim report, nor an earnings release or call transcript. It is not a proxy statement or voting result announcement. The content aligns with governance information about the company's internal incentive and assessment policies. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2628 characters, which is sufficient for a detailed governance policy document rather than a brief announcement.
2021-04-05 Chinese
第二届监事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting regarding the company's 2021 restricted stock incentive plan and related matters. It includes voting results and legal compliance statements but does not contain financial statements or detailed financial data. The document is relatively short (2374 characters) and primarily serves as a disclosure of board decisions and approvals, not a full report or financial filing. It is not an annual or interim report, earnings release, or audit report. It is also not a proxy solicitation or voting results announcement. The content fits best under Board/Management Information (MANG) as it relates to governance decisions and management-level approvals of incentive plans.
2021-04-05 Chinese
2021年限制性股票激励计划首次授予部分激励对象名单
Remuneration Information Classification · 95% confidence The document is a detailed list of recipients of restricted stock awards under a 2021 restricted stock incentive plan by 大博医疗科技股份有限公司 (DaBo Medical Technology Co., Ltd.). It includes names, positions, and stock quantities allocated to core management and technical personnel. The content focuses on stock incentive allocation and related personnel information, which is typical of announcements related to share-based compensation plans. There is no financial statement, earnings data, or regulatory certification present. The document is not a full annual or interim report, nor is it a voting result or management change announcement. It is a specific disclosure about stock incentive allocation to management and key personnel, which aligns best with Remuneration Information filings that detail compensation and incentive plans for executives and directors.
2021-04-05 Chinese
2021年限制性股票激励计划（草案）
Remuneration Information Classification · 95% confidence The document is a detailed draft of a 2021 restricted stock incentive plan for a company named 大博医疗科技股份有限公司. It includes comprehensive information about the stock incentive plan, such as the purpose, principles, management structure, scope of incentive recipients, stock source, quantity, distribution, effective period, grant date, lock-up period, release conditions, pricing, performance targets, and adjustment methods. The document is lengthy (15,000 characters) and contains substantive content about the company's stock incentive plan rather than just an announcement or summary. It is not a financial report like an annual or interim report, nor is it a regulatory filing or a simple announcement. It is a detailed management or governance document related to executive compensation and stock incentives. Given the nature of the content focusing on stock incentive plans and management-level equity awards, the most appropriate classification is Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors, including stock incentive plans.
2021-04-05 Chinese
中小企业板上市公司股权激励计划草案自查表
Governance Information Classification · 95% confidence The document is a detailed compliance self-checklist related to a draft equity incentive plan for a listed company, covering regulatory compliance, eligibility, disclosure, and procedural requirements. It is not a financial report, earnings release, or management discussion. It is not an announcement of voting results or a proxy statement. The content focuses on governance and regulatory compliance aspects of the equity incentive plan, including legal and procedural adherence, which aligns with governance information. The document is not a brief announcement but a substantive compliance checklist, indicating it is a governance-related filing rather than a simple announcement or regulatory filing. Therefore, the most appropriate classification is Governance Information (CGR).
2021-04-05 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.